Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation (Nasdaq: CELG), announced data from a study comparing melphalan, prednisone and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE